A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Massachusetts General Hospital
Thomas Jefferson University
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
University of Nebraska
Fred Hutchinson Cancer Center
Thomas Jefferson University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
University of Texas Southwestern Medical Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
University of Texas Southwestern Medical Center
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
OHSU Knight Cancer Institute
Barbara Ann Karmanos Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Rutgers, The State University of New Jersey
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
University of Chicago
National Cancer Institute (NCI)
Northside Hospital, Inc.
Northside Hospital, Inc.
National Cancer Institute (NCI)
University of California, San Francisco
Northside Hospital, Inc.
SWOG Cancer Research Network
Northside Hospital, Inc.
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)